Company / Income Tax per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.16
FY2025
5-year range
-$0.59 / $0.61
FY2021-FY2025
Trend
-126.4%
vs FY2024
Sector context
#191 of 201
Health Care
What the data says
Among 201 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the top 5% for income tax per share. Income Tax per Share has fluctuated over the past 10 years, ranging from $-202913.63 in FY2018 to $542143.60 in FY2016.
Based on SEC 10-K filings.
-0.16 in FY2025.
Improved from $-0.01 to $-0.16 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 201This company -$0.16 Sector average $1.35
▼
-111.9% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 126.4% year-over-year.
- Ranks #191 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2016.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.16 | -126.4% |
| FY2024 | $0.61 | +9731.0% |
| FY2023 | -$0.01 | +98.9% |
| FY2022 | -$0.59 | -403.6% |
| FY2021 | $0.19 | +217.5% |
| FY2020 | -$0.16 | +39.9% |
| FY2019 | -$0.27 | +100.0% |
| FY2018 | -$202913.63 | -10665200.0% |
| FY2017 | -$1.90 | -100.0% |
| FY2016 | $542143.60 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026